STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Synergy CHC Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Synergy CHC Corp. (SNYR) reported a Form 4 showing a stock option grant to Kenek Brands Inc., which is controlled by reporting person Jack Ross, the company's CEO and Chairman. The derivative award is a 750,000-share option with an exercise price of $2.38, recorded on 09/18/2025. The filing states the option vests one-third on the first anniversary of grant and the remaining two-thirds in equal monthly installments over the following 24 months, subject to continued service. The reporting person disclaims direct ownership; the shares are owned directly by Kenek Brands Inc., making Ross an indirect beneficial owner. The Form is signed by counsel on 09/22/2025.

Positive
  • Clear disclosure of a 750,000-share option grant with exercise price and vesting schedule
  • Vesting is time-based, aligning future executive service with potential equity realization
  • Indirect ownership and the reporting person's control of Kenek Brands Inc. are explicitly stated
Negative
  • Large option award (750,000 shares) may be material to shareholders though the filing does not quantify dilution
  • No performance conditions disclosed; award vests solely based on continued service per the filing
  • Form lacks grant valuation so economic impact is not quantified in the document

Insights

TL;DR: A routine insider option award is disclosed; control and indirect ownership are clearly stated.

The Form 4 documents a sizable option grant to an entity controlled by the CEO/chairman, clarifying indirect beneficial ownership and a time-based vesting schedule. The filing is straightforward and complies with Section 16 reporting requirements by disclosing transaction date, exercise price, number of options, and the vesting terms. There is no additional information on any performance conditions or accelerated vesting triggers; only time-based vesting is disclosed.

TL;DR: The award is large and time-vested, aligning pay with continued service but lacking performance conditions in the disclosure.

The grant of 750,000 options at a $2.38 strike is described with a clear one-third/then monthly vesting schedule over two years. From a compensation-design view, the award ties value to tenure and future stock performance. The disclosure does not include grant valuation, grant date beyond the transaction date, or any service conditions beyond continued service; it also confirms indirect ownership through Kenek Brands Inc.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ross Jack

(Last) (First) (Middle)
C/O SYNERGY CHC CORP.
865 SPRING STREET

(Street)
WESTBROOK ME 04092

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO and Chairman
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $2.38 09/18/2025 A 750,000 (1) 09/18/2030 Common Stock, par value $0.00001 per share 750,000 $0 750,000 I(2) By Kenek Brands Inc.
Explanation of Responses:
1. One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.
2. The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 09/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for SNYR disclose?

The Form 4 discloses a 750,000-share option grant at an exercise price of $2.38, dated 09/18/2025, to Kenek Brands Inc., controlled by Jack Ross.

Who is the reporting person on the SNYR Form 4?

The reporting person is Jack Ross, identified as CEO and Chairman, a director and a 10% owner; the reported securities are held by Kenek Brands Inc.

What are the vesting terms for the SNYR option grant?

The filing states one-third vests on the first anniversary of the grant and the remaining two-thirds vest in equal monthly installments over the following 24 months, subject to continued service.

Is the reported ownership direct or indirect for SNYR?

The reported securities are owned directly by Kenek Brands Inc.; the reporting person is the indirect beneficial owner and disclaims direct ownership except for pecuniary interest.

When was the Form 4 signed and filed for SNYR?

The signature block shows the form was signed by counsel on 09/22/2025 and the transaction date reported is 09/18/2025.
Synergy Chc Corp

NASDAQ:SNYR

SNYR Rankings

SNYR Latest News

SNYR Latest SEC Filings

SNYR Stock Data

22.22M
4.84M
56.75%
3.82%
1.06%
Medical Distribution
Medicinal Chemicals & Botanical Products
Link
United States
WESTBROOK